Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P17
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -21.08% |
| 2023 | -27.73% |
| 2022 | 9.70% |
| 2021 | 70.30% |
| 2020 | -0.43% |
| 2019 | 77.11% |
| 2018 | 0.00% |